Cargando…
Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure
BACKGROUND: A feedforward pathological signaling loop generated by TNFα and IFN-γ synergy in the inflamed lung, driving CXCL-10 (IP-10) and CXCL-9 chemokine-mediated activated T-cell and monocyte/macrophage tissue recruitment, may define the inflammatory biology of lethal COVID-19 respiratory failur...
Autores principales: | Hachem, Hilal, Godara, Amandeep, Schroeder, Courtney, Fein, Daniel, Mann, Hashim, Lawlor, Christian, Marshall, Jill, Klein, Andreas, Poutsiaka, Debra, Breeze, Janis L., Joshi, Raghav, Mathew, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376916/ https://www.ncbi.nlm.nih.gov/pubmed/34457357 http://dx.doi.org/10.1017/cts.2021.805 |
Ejemplares similares
-
499. Rapid and Sustained Decline in CXCL-10 (IP-10) Annotates Clinical Outcomes Following TNF-α Antagonist Therapy in Hospitalized Patients with Severe and Critical COVID-19 Respiratory Failure
por: Schroeder, Courtney, et al.
Publicado: (2021) -
An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012) -
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011) -
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
por: Liu, Mingli, et al.
Publicado: (2011) -
Macrophages induce differentiation of plasma cells through CXCL10/IP-10
por: Xu, Wei, et al.
Publicado: (2012)